PrimeGene

PrimeGene Therapeutics Co., Ltd. is an innovative pharmaceutical company based in China with a global outlook. The company focuses on addressing unmet clinical needs, specializing in the discovery, development, and commercialization of new drugs for immune/inflammatory diseases, with an emphasis on topical medications. It aims to become a world-leading pharmaceutical enterprise. PrimeGene concentrates on immunomodulation and inflammation targets, advancing new drug development in dermatology, ophthalmology, rhinology, and respiratory systems, while emphasizing translational medicine and biological discoveries. The company seeks synchronized global innovation and strives to evolve from a drug research and development firm into a comprehensive pharmaceutical technology enterprise.